Ashton Thomas Private Wealth, LLC Halozyme Therapeutics, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.83 Trillion
- Q2 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 3,720 shares of HALO stock, worth $224,799. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,720Holding current value
$224,799% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
487Shares Held
123MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$778 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$351 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$244 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$225 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.42B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...